layer so that data is actually ready to be consumed by AI – and then you build your products on top.” Bernd asserts.“ And beyond technology, you also need the right people and the right processes. The more you can standardise across countries and regulations, the easier it is to apply AI at scale.”
To accelerate scale and further strengthen the AI stack, Novartis works with external partners while keeping firm internal ownership of data, governance and product design. This includes, for example, a collaboration with Isomorphic
Labs – a drug discovery company owned by Alphabet, Google’ s parent company – on target identification in early-stage research.
Looking ahead: From AI to robotics to quantum Bernd’ s near-term focus is on what he calls a programmatic approach: selecting the right use cases, building strong cross-functional product teams and scaling what works rather than running an endless cycle of proof-of-concept experiments.
technologymagazine. com 69